Etanercept versus methotrexate in patients with early rheumatoid arthritis: Two‐year radiographic and clinical outcomes

573 indexed citations

Abstract

loading...

About

This paper, published in 2002, received 573 indexed citations. Written by Mark C. Genovese, Joan M. Bathon, Richard W. Martin, Roy Fleischmann, John Tesser, Michael Schiff, Edward Keystone, Mary Chester Wasko, Larry W. Moreland and Arthur L. Weaver covering the research area of Pathology and Forensic Medicine, Rheumatology and Hematology. It is primarily cited by scholars working on Rheumatology (525 citations), Hematology (273 citations) and Immunology (115 citations). Published in Arthritis & Rheumatism.

Countries where authors are citing Etanercept versus methotrexate in patients with early rheumatoid arthritis: Two‐year radiographic and clinical outcomes

Specialization
Citations

This map shows the geographic impact of Etanercept versus methotrexate in patients with early rheumatoid arthritis: Two‐year radiographic and clinical outcomes. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Etanercept versus methotrexate in patients with early rheumatoid arthritis: Two‐year radiographic and clinical outcomes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Etanercept versus methotrexate in patients with early rheumatoid arthritis: Two‐year radiographic and clinical outcomes more than expected).

Fields of papers citing Etanercept versus methotrexate in patients with early rheumatoid arthritis: Two‐year radiographic and clinical outcomes

Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of Etanercept versus methotrexate in patients with early rheumatoid arthritis: Two‐year radiographic and clinical outcomes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Etanercept versus methotrexate in patients with early rheumatoid arthritis: Two‐year radiographic and clinical outcomes.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

This paper is also available at doi.org/10.1002/art.10308.

Explore hit-papers with similar magnitude of impact

Rankless by CCL
2026